Important Causes of Visual Impairment in the World Today

JAMA

Volumn 290, Issue 15, 2003, Pages 2057-2060

  Congdon, Nathan G ^a,c   Friedman, David S ^a   Lietman, Thomas ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; EYE INFECTION; EYE INJURY; HUMAN; PRIORITY JOURNAL; REFRACTION ERROR; REVIEW; VISUAL IMPAIRMENT; CATARACT; DIABETIC RETINOPATHY; HEALTH; RETINA MACULA DEGENERATION; RETINOL DEFICIENCY; VISUAL DISORDER;

BLINDNESS; CATARACT; DIABETIC RETINOPATHY; EYE INFECTIONS; EYE INJURIES; HUMANS; MACULAR DEGENERATION; REFRACTIVE ERRORS; VISION, LOW; VITAMIN A DEFICIENCY; WORLD HEALTH;

EID: 0142088514     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.15.2057     Document Type: Review

References (63)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73:115-121.
2. Eye Disease Prevalence Study Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. In press.
3. Eye Disease Prevalence Study Group. The prevalence of refractive errors among middle-aged and elderly adults. Arch Ophthalmol. In press.
4. Dandona L, Dandona R, Srinivas M, et al. Blindness in the Indian state of Andhra Pradesh. Invest Ophthalmol Vis Sci. 2001;42:908-916.
5. Schein OD, Poggio EC. Ulcerative keratitis in contact lens wearers: incidence and risk factors. Cornea. 1990;9(suppl 1):S55-S58.
6. Stulting RD, Carr JD, Thompson KP, et al. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology. 1999;106:13-20.
7. Pierro L, Camesasca FI, Mischi M, Brancato R. Peripheral retinal changes and axial myopia. Retina. 1992; 12:12-17.
8. Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship between glaucoma and myopia. Ophthalmology. 1999;106:2010-2015.
9. Lim R, Mitchell P, Cumming RG. Refractive associations with cataract: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 1999;40:3021-3026.
10. Javitt JC, Chiang YP. The socioeconomic aspects of laser refractive surgery. Arch Ophthalmol. 1994; 112:1526-1530.
11. Eye Disease Prevalence Study Group. The prevalence of cataract and pseudophakia among adults in the United States. Arch Ophthalmol. In press.
12. Ellwein LB, Urato CJ. Use of eye care and associated charges among the Medicare population: 1991-1998. Arch Ophthalmol. 2002;120:804-811.
13. Congdon NG. Prevention strategies for age-related cataract: present limitations and future possibilities. Br J Ophthalmol. 2001;85:516-520.
14. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. Arch Ophthalmol. 2001;119:1439-1452.
15. McCarty CA, Nanjan MB, Taylor HR. Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci. 2000; 41:3720-3725.
16. Kupfer C. Bowman lecture: the conquest of cataract: a global challenge. Trans Ophthalmol Soc UK. 1985;104:1-10
17. Taylor HR. Cataract: a global public health challenge. In: Pararajasigaram R, Rao GN, eds. World Blindness and Its Prevention, Volume 6: The Proceedings of the IAPB Sixth General Assembly, Beijing, September 1999. Hyderabad, India: International Agency for the Prevention of Blindness; 2001.
18. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
19. Eye Disease Prevalence Study Group. The prevalence of glaucoma among adults in the United States. Arch Ophthalmol. In press.
20. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
21. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol. 2002;120: 701-713.
22. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
23. Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001;85:1277-1282.
24. Eye Disease Prevalence Study Group. The prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. In press.
25. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.
26. Seddon JM, Willett WC, Speizer RD, Hankinson SE. A prospective study of cigarette smoking and risk of age-related macular degeneration in women. JAMA. 1996;276:1141-1146.
27. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
28. Reacher MH, Huber MJ, Canagaratnam R, Alghassany A. A trial of surgery for trichiasis of the upper lid from trachoma. Br J Ophthalmol. 1990;74: 109-113.
29. Grayston JT, Wang S-P. New knowledge of chlamydiae and the diseases they cause. J Infect Dis. 1975; 132:87-105.
30. West S, Munoz B, Lynch M, et al. Impact of face washing on trachoma in Kongwa, Tanzania. Lancet. 1995;345:155-158.
31. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630-635.
32. Taylor HR, Pacque M, Munoz B, Greene BM. Impact of mass treatment of onchocerciasis with invermetin on the transmission of infection. Science. 1990; 250:116-118.
33. Saint Andre A, Blackwell NM, Hall LR, et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science. 2002;295:1892-1895.
34. Cunningham ETJ, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339: 236-244.
35. Jacobson MA, Stanley H, Holtzer C, et al. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30: 231-233.
36. Harris EW, Loewenstein JI, Azar D. Vitamin A deficiency and its effects on the eye. Int Ophthalmol Clin. 1998;38:155-161.
37. Congdon NG, West KP Jr. Nutrition and the eye. Curr Opin Ophthalmol. 1999;10:464-473.
38. Sommer A, Tarwotjo I, Djunaedi E, et al. Impact of vitamin supplementation on childhood mortality: a randomized, controlled clinical trial. Lancet. 1986; 1:1169-1173.
39. Sommer A, West KP Jr. Vitamin A Deficiency: Health, Survival and Vision. New York, NY: Oxford University Press; 1996:6-7.
40. West KP Jr, Katz J, Khatry SK, et al, for the NNIPS-2 Study Group. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. BMJ. 1999;318:570-575.
41. Humphrey JH, West KP Jr, Sommer A. Vitamin A deficiency and attributable mortality among under-5-year-olds. Bull World Health Organ. 1992;70:225-232.
42. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102:527-532.
43. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV: ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
44. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154:2169-2178.
45. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extensive of the modified Airlie House Classification. Ophthatmology. 1991;98:786-806.
46. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81:383-396.
47. Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type I diabetes mellitus: savings associated with improved implementation of current guidelines. Ophthalmology. 1991; 98:1565-1573.
48. Narendran V, John RK, Raghuram A, et al. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol. 2002;86:1014-108.
49. Tielsch JM, Parver LM. Determinants of hospital charges and length of stay for ocular trauma. Ophthalmology. 1990;97:231-237.
50. Leads from MMWR: leading work-related diseases and injuries-United States. JAMA. 1990;251: 2503-2504.
51. Thylefors B. Epidemiologic patterns of ocular trauma. Aust N Z J Ophthalmol. 1992;20:95-98.
52. Schein OD, Hibberd PL, Shingleton BJ, et al. The spectrum and burden of ocular injury. Ophthalmology. 1988;95:300-305.
53. Katz J, Tielsch JM. Lifetime prevalence of ocular injuries from the Baltimore Eye Survey. Arch Ophthalmol. 1993;111:1564-1568.
54. Parver LM, Dannenberg AL, Blacklow B, et al. Characteristics and causes of penetrating eye injuries reported to the National Eye Trauma System Registry. Public Health Rep. 1993;108:625-632.
55. Garrow A. A statistical inquiry into 100 cases of eye injuries. Br J Ophthalmol. 1923;7:65-80.
56. Brilliant LB, Pokhrel RP, Grasset NC, et al. Epidemiology of blindness in Nepal. Bull World Health Organ. 1985;63:375-386.
57. Rehki GS, Kulshreshtha OP. Common causes of blindness: a pilot study in Jaipur, Rajasthan. Ind J Ophthalmol. 1991;39:108-111.
58. Congdon NG, Schein OD. The epidemiology of ocular trauma: a preventable ocular emergency. In: MacCumber M, ed. Management of ocular Injuries and Emergencies. Philadelphia, Pa: Lippincott Williams & Wilkins: 1998:9-19.
59. Larrison WI, Hersh PS, Kunzweiler T, Shingleton BJ. Sports-related ocular trauma. Ophthalmology. 1990;97:1265-1269.
60. Pashby TJ. Eye injuries in Canadian hockey, phase III: older players now most at risk. CMAJ. 1979;121: 643-644.
61. Schein OD, Enger C, Tielsch JM. The context and consequences of ocular injuries from airguns. Am J Ophthalmol. 1994;117:501-506.
62. Dannenberg AL, Parver LM, Fowler CJ. Penetrating eye injuries related to assault: the National Eye Trauma System Registry. Arch Ophthalmol. 1992; 110:849-852.
63. Frick KD, Foster A. The magnitude and cost of global blindness. Am J Ophthalmol. 2003;135:471-476.